Generic name | ticlopidine |
Strength | 250 mg |
Form | tablet |
Special Authority criteria |
Approval period |
---|---|
For use in secondary prevention of coronary, cerebral and peripheral vascular occlusion and embolization where patient has experienced failure on or intolerance to ASA. |
Indefinite |